These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26318908)

  • 1. The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.
    Tsoumpra MK; Muniz JR; Barnett BL; Kwaasi AA; Pilka ES; Kavanagh KL; Evdokimov A; Walter RL; Von Delft F; Ebetino FH; Oppermann U; Russell RGG; Dunford JE
    Bone; 2015 Dec; 81():478-486. PubMed ID: 26318908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
    Kavanagh KL; Guo K; Dunford JE; Wu X; Knapp S; Ebetino FH; Rogers MJ; Russell RG; Oppermann U
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7829-34. PubMed ID: 16684881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
    Stresing V; Fournier PG; Bellahcène A; Benzaïd I; Mönkkönen H; Colombel M; Ebetino FH; Castronovo V; Clézardin P
    Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme's active site closure.
    Park J; Lin YS; De Schutter JW; Tsantrizos YS; Berghuis AM
    BMC Struct Biol; 2012 Dec; 12():32. PubMed ID: 23234314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesyl pyrophosphate synthase: real-time kinetics and inhibition by nitrogen-containing bisphosphonates in a scintillation assay.
    Glickman JF; Schmid A
    Assay Drug Dev Technol; 2007 Apr; 5(2):205-14. PubMed ID: 17477829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer.
    Huang CH; Gabelli SB; Oldfield E; Amzel LM
    Proteins; 2010 Mar; 78(4):888-99. PubMed ID: 19876942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase.
    Ohno K; Mori K; Orita M; Takeuchi M
    Curr Med Chem; 2011; 18(2):220-33. PubMed ID: 21110804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates.
    Aripirala S; Gonzalez-Pacanowska D; Oldfield E; Kaiser M; Amzel LM; Gabelli SB
    Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):802-10. PubMed ID: 24598749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.
    Räikkönen J; Taskinen M; Dunford JE; Mönkkönen H; Auriola S; Mönkkönen J
    Biochem Biophys Res Commun; 2011 Apr; 407(4):663-7. PubMed ID: 21420384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
    Dunford JE; Kwaasi AA; Rogers MJ; Barnett BL; Ebetino FH; Russell RG; Oppermann U; Kavanagh KL
    J Med Chem; 2008 Apr; 51(7):2187-95. PubMed ID: 18327899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition.
    Fernández D; Ortega-Castro J; Mariño L; Perelló J; Frau J
    J Comput Aided Mol Des; 2015 Jul; 29(7):667-80. PubMed ID: 26081258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase from Pseudomonas aeruginosa.
    Schmidberger JW; Schnell R; Schneider G
    Acta Crystallogr D Biol Crystallogr; 2015 Mar; 71(Pt 3):721-31. PubMed ID: 25760619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR, molecular docking, and ONIOM studies on the structure-activity relationships and action mechanism of nitrogen-containing bisphosphonates.
    Liu QZ; Wang SS; Li X; Zhao XY; Li K; Lv GC; Qiu L; Lin JG
    Chem Biol Drug Des; 2018 Mar; 91(3):735-746. PubMed ID: 29080272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into human farnesyl pyrophosphate synthase inhibition by second-generation bisphosphonate drugs.
    Fernández D; Ramis R; Ortega-Castro J; Casasnovas R; Vilanova B; Frau J
    J Comput Aided Mol Des; 2017 Jul; 31(7):675-688. PubMed ID: 28631130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization and preliminary neutron diffraction experiment of human farnesyl pyrophosphate synthase complexed with risedronate.
    Yokoyama T; Ostermann A; Mizuguchi M; Niimura N; Schrader TE; Tanaka I
    Acta Crystallogr F Struct Biol Commun; 2014 Apr; 70(Pt 4):470-2. PubMed ID: 24699741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of human farnesyl pyrophosphate synthase in complex with an aminopyridine bisphosphonate and two molecules of inorganic phosphate.
    Park J; Lin YS; Tsantrizos YS; Berghuis AM
    Acta Crystallogr F Struct Biol Commun; 2014 Mar; 70(Pt 3):299-304. PubMed ID: 24598914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.
    Leung CY; Park J; De Schutter JW; Sebag M; Berghuis AM; Tsantrizos YS
    J Med Chem; 2013 Oct; 56(20):7939-50. PubMed ID: 23998921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protonation State and Hydration of Bisphosphonate Bound to Farnesyl Pyrophosphate Synthase.
    Yokoyama T; Mizuguchi M; Ostermann A; Kusaka K; Niimura N; Schrader TE; Tanaka I
    J Med Chem; 2015 Sep; 58(18):7549-56. PubMed ID: 26314394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the N-BP Binding at FPPS by Combined Computational Approaches.
    Stefanucci A; Marrone A; Agamennone M
    Med Chem; 2015; 11(5):417-31. PubMed ID: 25541745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.